A-wave |
late diastolic mitral flow velocity |
AGE |
advanced glycation end products |
ANOVA |
analysis of variance |
AO |
aorta diameter |
C |
control group |
C + DAPA |
control group treated with dapagloflozin |
DAB |
3,3′-diaminobenzidine |
DM |
diabetes mellitus |
DM + DAPA |
diabetes mellitus group treated with dapagloflozin |
E-wave |
early diastolic mitral flow velocity |
E/A |
ratio |
E/E’ |
ratio |
EDT |
E-wave deceleration time |
EDTA |
ethylenediamine tetraacetic acid |
EFS |
endocardial fraction shortening |
GSH-Px |
glutathione peroxidase |
HOP |
hydroxyproline |
H2O2
|
Hydrogen peroxide |
IVRT |
isovolumetric relation time |
LA |
left atrium |
LV |
left ventricle |
LVDD |
left ventricle diastolic dimensions |
LVPWT |
left ventricle posterior wall thickness |
LVM |
left ventricle mass |
LVSWT |
left ventricle septal wall thickness |
LVSD |
left ventricle sistolic dimensions |
NADH |
nicotinamida adenina dinucleotídeo |
PWSV |
posterior wall shortening velocity |
RWT |
left ventricle relative wall thickness |
SGLT2 |
sodium-glucose co-transporter 2 |
SOD |
superoxide dismutase |
TDI |
tissue Doppler imaging |
TDI-A’ |
tissue Doppler imaging of mitral annular late velocity (lateral, septal and average) |
TDI-E’ |
tissue Doppler imaging of mitral annular early velocity (lateral, septal and average) |
TDI-S’ |
tissue Doppler imaging for systolic velocity of the mitral annulus (lateral, septal and average) |
Tei index |
myocardial performance index |